Results 241 to 250 of about 3,558,527 (312)

Revisiting Mission‐Oriented Cancer Research to tackle the increasing burden of cancer in Europe–a policy perspective

Molecular Oncology, EarlyView.
Translational cancer research and its implementation through competitively selected Comprehensive Cancer Centers across Europe should be the primary policy focus for addressing the increasing cancer burden in Europe and counteract the present main strategy to convert cancer to a chronic disease.
Manuel Heitor, Julio Celis, Ulrik Ringborg   +2 more
wiley   +1 more source

A decade on: exploring the Okanagan Charter's continued international relevance for health promotion in higher education. [PDF]

Health Promot Int
Noonan A, Tierney A, Norton C, McNally K, Woods CB.   +4 more
europepmc   +1 more source

Insights into a long life without cancer: The case of the bowhead whale

Molecular Oncology, EarlyView.
Long‐lived, large‐bodied organisms have evolved powerful anticancer mechanisms that preserve cellular and tissue integrity across extended lifespans. A recent study by Firsanov et al. shows that greater genome stability is a key factor underlying the remarkable longevity and cancer resistance of one such species, the bowhead whale.
Inés Paniagua, Johanna A. Joyce
wiley   +1 more source

Evaluating multiple candidates simultaneously reduces racial disparities in promotion and tenure. [PDF]

Nat Commun
Masters-Waage TC, Madera JM, Edema-Sillo E, St Aubin A, Lindner P, Gaytan M, Yu H, Spitzmueller C.   +7 more
europepmc   +1 more source

Integration of a WASH Component in the Standard National Protocol for Treatment of Severe Acute Malnutrition in Children Aged 6-59 Months in Northern Senegal-A Costing Study. [PDF]

Matern Child Nutr
Wassonguema B, Lê-Lacanette M, Braun L, Ba M, Siroma F, Cabo AE, Brizuela AV, Seye M, Lapègue J, Devort A, Cumming O, N'Diaye DS.   +11 more
europepmc   +1 more source

Proteasome inhibitor, ixazomib prevents topoisomerase‐I degradation and reverses irinotecan resistance in colorectal cancer

Molecular Oncology, EarlyView.
Ixazomib inhibits proteasome‐mediated degradation of topoisomerase I induced by irinotecan, thereby restoring drug sensitivity and promoting tumor cell death in colorectal cancer. Irinotecan, a topoisomerase I (topoI) inhibitor, is widely used for colorectal cancer, but resistance remains a major clinical challenge.
Yuho Ebata, Koji Ando, Hirofumi Hasuda, Koshi Mimori, Elizabeth C. Unan, Siddhartha Pulukuri, Aahana Tiku, Allison Berger, Eiji Oki, Ajit Bharti, Tomoharu Yoshizumi   +10 more
wiley   +1 more source

Neural circuits for decision-making based on pineal photoreception in zebrafish. [PDF]

Proc Natl Acad Sci U S A
Wada S, Yamamoto Y, Saito T, Hibi M, Koyanagi M, Terakita A.   +5 more
europepmc   +1 more source

University library reading promotion and college students' cultural development: a meta-analysis of psychological mechanisms and moderating effects. [PDF]

Front Psychol
Zhao J.
europepmc   +1 more source

Lattice softening and diffusive dynamics in the polar metal LiReO₃. [PDF]

Sci Adv
Murayama K, Masuki R, Tassel C, Sakai H, Yanagisawa T, Yoshida K, Oike H, Yoshida S, Gu X, Ishida K, Namba M, Denisova K, Dupray V, Clevers S, Mentré O, Nomoto T, Tadano T, Brown CM, Lemmens P, Arita R, Takatsu H, Kageyama H.   +21 more
europepmc   +1 more source

Editorial: Implementing mental health prevention and promotion programs: a sustainable approach, volume II. [PDF]

Front Psychol
Santos de Carvalho CM, Gascón-Santos S, Alacreu-Crespo A, Ordoñez-Carrasco JL.   +3 more
europepmc   +1 more source